Logo image of DHCNL

DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) Stock Fundamental Analysis

USA - NASDAQ:DHCNL - US25525P3055

17.65 USD
0 (0%)
Last: 10/17/2025, 8:06:44 PM
Fundamental Rating

2

Taking everything into account, DHCNL scores 2 out of 10 in our fundamental rating. DHCNL was compared to 127 industry peers in the Diversified REITs industry. While DHCNL seems to be doing ok healthwise, there are quite some concerns on its profitability. DHCNL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year DHCNL has reported negative net income.
In the past year DHCNL had a positive cash flow from operations.
In the past 5 years DHCNL reported 4 times negative net income.
In multiple years DHCNL reported negative operating cash flow during the last 5 years.
DHCNL Yearly Net Income VS EBIT VS OCF VS FCFDHCNL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

The Return On Assets of DHCNL (-6.03%) is worse than 85.83% of its industry peers.
Looking at the Return On Equity, with a value of -15.46%, DHCNL is doing worse than 81.10% of the companies in the same industry.
Industry RankSector Rank
ROA -6.03%
ROE -15.46%
ROIC N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
DHCNL Yearly ROA, ROE, ROICDHCNL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

DHCNL has a Gross Margin of 17.80%. This is amonst the worse of the industry: DHCNL underperforms 94.49% of its industry peers.
DHCNL's Gross Margin has declined in the last couple of years.
DHCNL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
DHCNL Yearly Profit, Operating, Gross MarginsDHCNL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

4

2. Health

2.1 Basic Checks

DHCNL does not have a ROIC to compare to the WACC, probably because it is not profitable.
DHCNL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DHCNL has more shares outstanding
The debt/assets ratio for DHCNL is higher compared to a year ago.
DHCNL Yearly Shares OutstandingDHCNL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
DHCNL Yearly Total Debt VS Total AssetsDHCNL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.38, we must say that DHCNL is in the distress zone and has some risk of bankruptcy.
DHCNL's Altman-Z score of 0.38 is in line compared to the rest of the industry. DHCNL outperforms 40.16% of its industry peers.
DHCNL has a Debt/Equity ratio of 1.42. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of DHCNL (1.42) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Altman-Z 0.38
ROIC/WACCN/A
WACC6.64%
DHCNL Yearly LT Debt VS Equity VS FCFDHCNL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

DHCNL has a Current Ratio of 3.37. This indicates that DHCNL is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of DHCNL (3.37) is better than 91.34% of its industry peers.
A Quick Ratio of 3.37 indicates that DHCNL has no problem at all paying its short term obligations.
DHCNL's Quick ratio of 3.37 is amongst the best of the industry. DHCNL outperforms 91.34% of its industry peers.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 3.37
DHCNL Yearly Current Assets VS Current LiabilitesDHCNL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

DHCNL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.64%, which is quite impressive.
DHCNL shows a small growth in Revenue. In the last year, the Revenue has grown by 4.29%.
DHCNL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.53% yearly.
EPS 1Y (TTM)39.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8.57%
Revenue 1Y (TTM)4.29%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%3.05%

3.2 Future

DHCNL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.46% yearly.
The Revenue is expected to grow by 3.37% on average over the next years.
EPS Next Y20.16%
EPS Next 2Y17.46%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.66%
Revenue Next 2Y3.37%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DHCNL Yearly Revenue VS EstimatesDHCNL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
DHCNL Yearly EPS VS EstimatesDHCNL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1

0

4. Valuation

4.1 Price/Earnings Ratio

DHCNL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DHCNL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DHCNL Price Earnings VS Forward Price EarningsDHCNL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

DHCNL's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. DHCNL is more expensive than 94.49% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.36
DHCNL Per share dataDHCNL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

DHCNL's earnings are expected to grow with 17.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.46%
EPS Next 3YN/A

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.98%, DHCNL is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.23, DHCNL's dividend is way lower than its industry peers. On top of this 90.55% of the companies listed in the same industry pay a better dividend than DHCNL!
Compared to an average S&P500 Dividend Yield of 2.36, DHCNL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.98%

5.2 History

The dividend of DHCNL decreases each year by -45.60%.
DHCNL has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-45.6%
Div Incr Years0
Div Non Decr Years0
DHCNL Yearly Dividends per shareDHCNL Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of DHCNL are negative and hence is the payout ratio. DHCNL will probably not be able to sustain this dividend level.
DP-3.36%
EPS Next 2Y17.46%
EPS Next 3YN/A
DHCNL Yearly Income VS Free CF VS DividendDHCNL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46

NASDAQ:DHCNL (10/17/2025, 8:06:44 PM)

17.65

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners75.89%
Inst Owner ChangeN/A
Ins Owners0.48%
Ins Owner ChangeN/A
Market Cap4.26B
Analysts48
Price Target17.82 (0.96%)
Short Float %0.01%
Short Ratio1.45
Dividend
Industry RankSector Rank
Dividend Yield 0.98%
Yearly Dividend0.04
Dividend Growth(5Y)-45.6%
DP-3.36%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-15 2025-08-15 (0.390625)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)25.74%
Min EPS beat(2)-71.02%
Max EPS beat(2)122.5%
EPS beat(4)2
Avg EPS beat(4)34.05%
Min EPS beat(4)-71.02%
Max EPS beat(4)122.5%
EPS beat(8)3
Avg EPS beat(8)16.12%
EPS beat(12)4
Avg EPS beat(12)5.38%
EPS beat(16)4
Avg EPS beat(16)-11.59%
Revenue beat(2)0
Avg Revenue beat(2)-0.26%
Min Revenue beat(2)-0.49%
Max Revenue beat(2)-0.04%
Revenue beat(4)1
Avg Revenue beat(4)-0.41%
Min Revenue beat(4)-2.43%
Max Revenue beat(4)1.32%
Revenue beat(8)2
Avg Revenue beat(8)-0.47%
Revenue beat(12)4
Avg Revenue beat(12)-0.38%
Revenue beat(16)4
Avg Revenue beat(16)-1.01%
PT rev (1m)8.18%
PT rev (3m)2.53%
EPS NQ rev (1m)-2.38%
EPS NQ rev (3m)-7.5%
EPS NY rev (1m)-12.16%
EPS NY rev (3m)-28.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.8
P/FCF N/A
P/OCF 47.82
P/B 2.3
P/tB 2.3
EV/EBITDA 28.36
EPS(TTM)-0.67
EYN/A
EPS(NY)-0.65
Fwd EYN/A
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)0.37
OCFY2.09%
SpS6.31
BVpS7.68
TBVpS7.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.03%
ROE -15.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.8%
FCFM N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
F-Score6
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Debt/EBITDA 11.07
Cap/Depr 66.82%
Cap/Sales 12.33%
Interest Coverage N/A
Cash Conversion 37.41%
Profit Quality N/A
Current Ratio 3.37
Quick Ratio 3.37
Altman-Z 0.38
F-Score6
WACC6.64%
ROIC/WACCN/A
Cap/Depr(3y)103.34%
Cap/Depr(5y)92.72%
Cap/Sales(3y)19.78%
Cap/Sales(5y)17.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8.57%
EPS Next Y20.16%
EPS Next 2Y17.46%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.29%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%3.05%
Revenue Next Year3.66%
Revenue Next 2Y3.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y38.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year377.31%
EBIT Next 3Y72.02%
EBIT Next 5YN/A
FCF growth 1Y71.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y283.65%
OCF growth 3YN/A
OCF growth 5Y-15.84%